Meanwhile, anti‐FGF2 monoclonal antibody (3F12E7) could decrease newborn lymphatic vessels in both intratumoral and peritumoral regions of orthotopic uterine tumors (Figure S11G–I, Supporting Information). Here, FGF2 is linked to tumor of uterus.